Michael Peters, MD, on IL-6 as a Biomarker for Asthma Exacerbations

Published: Nov. 2, 2020, 9:21 p.m.

In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of\xa0blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3 years. More at www.consultant360.com/pulmonology.